Tacrolimus
- Product NDC
- 54288-133
- 11-digit product format
- 542880133
- Labeler code
- 54288
- Product ID
- 54288-133_f2e9bcc1-fc42-4fab-a6b2-aceaa77fb2b9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tacrolimus
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- BPI Labs LLC
- Application
- ANDA206651
- Marketing category
- ANDA
- Marketing start
- 2020-04-08
- Substance
- TACROLIMUS
- Active strength
- 5 mg/1
- Pharmacologic classes
- Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| WM0HAQ4WNM | TACROLIMUS | 109581-93-3 | TACROLIMUS |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 54288-133-01 | 54288013301 | 100 CAPSULE in 1 BOTTLE (54288-133-01) | 100 capsule | 2020-04-08 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Tacrolimus | BPI Labs LLC | AJENAT PHARMACEUTICALS LLC | 2026-01-06 | HUMAN PRESCRIPTION DRUG LABEL | 12 |